![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, April 11, 2020 3:18:44 AM
The singular and most important goal for NWBO is to obtain regulatory approvals. And...the most important agency is NWBO's own national agency, the FDA.
Upon information and belief, the hold and its length of imposition was due to unsavory elements within the FDA and was finally lifted when higher management eschalons were confronted with Intel/evidence of corruption, conspiracies and illegal actions flowing therefrom by Mr. Black and his operatives. NWBO reached an agreement with the agency that it would be treated fairly and impartially and with reasonable expedition. The top management of the FDA wanted to avoid a scandal and NWBO wanted assurances that its application would be treated strictly on its merits. As part of a win-win compromise, the FDA agreed to re-examine its decisional criteria with respect to novel therapeutic approaches with substantial input from NWBO and NWBO modified its SAP in accordance with the new and much more flexible guidelines.
While NWBO has a certain leverage wrt the FDA, it is important that they show undeniable results that minimize if not eliminate any questions and, accordingly, NWBO is double and even triple checking the data and its accuracy and making sure that it has all the necessary data collected before data lock. NWBO wants to avoid, at all costs, regulatory delays in approvals such as, for example, a CRL which in itself could cause considerable delays and even engender a phase IV trial, not to mention the severe impact upon the SP and ithe ability to obtain favorable financing.
If the foregoing is a roughly accurate broad picture of what has transpired, Mr. Black has much more than earned his keep. We may never know the full story due to the players involved but can thank Mr. Black for his crucial,role in helping NWBO across the goal line.
In any event, I think Mr. Black has played and is playing a very important but very clandestine role in assuring to all extents possible NWBO' obtaining FDA approvals. Les has mentioned several times that NWBO's Intel is very good and not to sell Cofer Black short. I think there is something to that. Just a thought FWIW.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM